Matches in Wikidata for { <http://www.wikidata.org/entity/Q64626254> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q64626254 description "clinical trial" @default.
- Q64626254 description "ensayu clínicu" @default.
- Q64626254 description "klinisch onderzoek" @default.
- Q64626254 description "клінічне випробування" @default.
- Q64626254 name "GRASPA Treatment for Patients With Acute Myeloblastic Leukemia" @default.
- Q64626254 type Item @default.
- Q64626254 label "GRASPA Treatment for Patients With Acute Myeloblastic Leukemia" @default.
- Q64626254 prefLabel "GRASPA Treatment for Patients With Acute Myeloblastic Leukemia" @default.
- Q64626254 P1050 Q64626254-FCF5A92E-314A-464D-96A9-DEB120D3AA5F @default.
- Q64626254 P1132 Q64626254-863AC396-892A-4BE5-917B-354E4B4AB560 @default.
- Q64626254 P1476 Q64626254-8A2BCC35-39A3-4A9A-AAC9-51E22F86E05B @default.
- Q64626254 P17 Q64626254-3658AC33-6867-48B6-9ABA-69F28853AD7E @default.
- Q64626254 P1813 Q64626254-BD7FE344-F569-4A4A-9EB5-9A623EE0BB53 @default.
- Q64626254 P2899 Q64626254-254E001A-54E9-4671-B35C-CFF041D8DEE5 @default.
- Q64626254 P3098 Q64626254-326EDA37-528B-4251-9EFC-59CEBD7D79B5 @default.
- Q64626254 P31 Q64626254-1DB412F9-D09B-480C-8CCA-4D3CCEC42D29 @default.
- Q64626254 P4135 Q64626254-703F4F1B-0A8A-4031-B565-0B1DA9FFEB7E @default.
- Q64626254 P4844 Q64626254-2B47EECE-7692-4A92-85DC-876EFC417CE2 @default.
- Q64626254 P4844 Q64626254-824001C2-ADD2-441B-996F-93A0EE8749A4 @default.
- Q64626254 P580 Q64626254-D2002FA8-8813-4106-82A1-A65AD00A300A @default.
- Q64626254 P582 Q64626254-475FFE3E-AF66-4829-8343-BE9FEB5837FF @default.
- Q64626254 P6099 Q64626254-D77B089C-FB85-44FF-B81B-A822C7683F3F @default.
- Q64626254 P6153 Q64626254-50FA1E43-6BCF-404B-AAAF-BE5BDA4F1452 @default.
- Q64626254 P6153 Q64626254-6DDFA02D-1DFF-45BE-AFB3-2E00B0903E0C @default.
- Q64626254 P8363 Q64626254-9C66561C-0CF3-4EB3-A406-5DB4183AA27C @default.
- Q64626254 P1050 Q29496 @default.
- Q64626254 P1132 "+123" @default.
- Q64626254 P1476 "A Multicenter, Open, Randomized, Controlled Phase IIb Trial Evaluating Efficacy and Tolerability of GRASPA (L-asparaginase Encapsulated in Red Blood Cells, Eryaspase) Plus Low-dose Cytarabine vs Low-dose Cytarabine Alone, in Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) Elderly Patients, Unfit for Intensive Chemotherapy" @default.
- Q64626254 P17 Q142 @default.
- Q64626254 P1813 "ENFORCE" @default.
- Q64626254 P2899 "+65" @default.
- Q64626254 P3098 "NCT01810705" @default.
- Q64626254 P31 Q30612 @default.
- Q64626254 P4135 "+85" @default.
- Q64626254 P4844 Q180983 @default.
- Q64626254 P4844 Q421534 @default.
- Q64626254 P580 "2013-02-01T00:00:00Z" @default.
- Q64626254 P582 "2017-11-10T00:00:00Z" @default.
- Q64626254 P6099 Q42824440 @default.
- Q64626254 P6153 Q2944818 @default.
- Q64626254 P6153 Q2945675 @default.
- Q64626254 P8363 Q78089383 @default.